Skip to main content
SpringerLink
Log in

Prädiktoren für den antidepressiven Therapieerfolg

  • Conference paper
Book cover Differenzierte Therapie mit trizyklischen Antidepressiva

  • 49 Accesses

Zusammenfassung

Depressive Erkrankungen zählen neben Angsterkrankungen und dem Alkoholismus zu den häufigsten psychischen Erkrankungen überhaupt. Epidemiologische Studien legen darüber hinaus die Vermutung nahe, daß die Häufigkeit depressiver Erkrankungen eher noch zunehmen wird (Hagnell et al. 1982; Weissman et al. 1984). Depressive Erkrankungen sind ohne Zweifel äußerst heterogen; ihre Behandlungsmethoden reichen von kognitiven oder psychoanalytisch orientierten Psychotherapieformen über die Schlafentzugsbehandlung, die Lichtbehandlung und die Antidepressivabehandlung bis hin zur Elektrokrampftherapie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aberg-Wistedt A, Jostell KG, Ross SB, Westland D (1981) Effects of zimelidine and desimi-pramine on serotonin and noradrenaline uptake mechanism in relation to plasma concentration and to therapeutic effects during treatment of depression. Psychopharmacology 74:297–305

    Article  PubMed  CAS  Google Scholar 

  • Akiskal HS (1982) Factors associated with incomplete recovery in primary depressive illness. J Clin Psychiatry 43:266–271

    PubMed  CAS  Google Scholar 

  • Amin (1978) Response to sleep deprivation and therapeutic results with antidepressants. Lancet 2:165

    Article  PubMed  CAS  Google Scholar 

  • Ananth J (1978) Clinical prediction of antidepressant response. Int Pharmacopsychiatry 13:69–93

    PubMed  CAS  Google Scholar 

  • Angst J (1961) A clinical analysis of the effects of Tofranil in depression. Longitudinal and follow-up studies. Treatment of blood relations. Psychopharmakologia 2:381–407

    Article  CAS  Google Scholar 

  • Angst J (1965) Zur Prognose antidepressiver Behandlungen. Anglo-Germ Med Rev 2:733–751

    CAS  Google Scholar 

  • Ansseau M, Kupfer D-J, Reynolds C-F, Coble PA (1985) „Paradoxical” shortening of REM latency on first recording night in major depressive disorder: clinical and Polysomnographic correlates. Biol Psychiatry 20:135–145

    Article  PubMed  CAS  Google Scholar 

  • Arana GW, Baldessarini RJ, Ornsteen M (1985) The dexamethasone suppression test for diagnosis and prognosis in psychiatry: commentary and review. Arch Gen Psychiatry 42:1193–1204

    PubMed  CAS  Google Scholar 

  • Asberg M, Bertilsson L, Tuck D, Cronholm B, Sjöquist F (1973) Indoleamine metabolites in cerebrospinal fluid of depressed patients before and during treatment with nortriptyline. Clin Pharmacol Ther 14:277–286

    PubMed  CAS  Google Scholar 

  • Banki CM (1977) Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindolacetic acid in depressed women. J Neural Transm 47:135–145

    Article  Google Scholar 

  • Beckmann H, Goodwin FK (1975) Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Arch Gen Psychiatry 32:17–21

    PubMed  CAS  Google Scholar 

  • Deykin EY, DiMascio A (1972) Relationship of patient background characteristics to efficacy of pharmacotherapy in depression. J Nerv Ment Dis 155:209–215

    Article  PubMed  CAS  Google Scholar 

  • Downing RW, Rickeis K (1973) Predictor of response to amitriptyline and placebo in three outpatient treatment settings. J Nerv Ment Dis 156:109–129

    Article  PubMed  CAS  Google Scholar 

  • Ebert MH, Post RM, Goodwin FK (1972) Effect of physical activity on urinary MHPG excretion in depressed patients. Lancet 2:766

    Article  PubMed  CAS  Google Scholar 

  • Ettigi PG, Hayes PE, Narasimhachari N, Hamer RM, Goldberg S, Second GJ (1983) d-Amphetamine response and dexamethasone suppression test as predictors of treatment outcome in unipolar depression. Biol Psychiatry 18:499–504

    PubMed  CAS  Google Scholar 

  • Fähndrich E (1983 a) Clinical and biological parameters as predictors for antidepressive drug response in depressed patients. Pharmacopsychiatry 16:179–185

    Article  Google Scholar 

  • Fähndrich E (1983 b) Effect of sleep deprivation as a predictor of treatment response to antidepressant medication. Acta Psychiatr Scand 68:341–344

    Article  PubMed  Google Scholar 

  • Fähndrich E (1987) Biological predictors of success of antidepressant drug therapy. Psychiat Develop 2:157–171

    Google Scholar 

  • Fähndrich E (1990) Biologische Prädiktoren für eine erfolgreiche antidepressive medikamentöse Behandlung. In: Möller HJ (Hrsg) Therapieresistenz unter Antidepressiva-Behand-lung. Springer, Berlin Heidelberg New York Tokyo, pp 43–57

    Google Scholar 

  • Fairchild CJ, Rush AJ, Vasavada N, Giles DE, Khatami M (1986) Which depressions respond to placebo. Psychiatr Res 18:217–226

    Article  CAS  Google Scholar 

  • Fawcett J, Siomopoulos V (1971) Dextroamphetamine response as a possible predictor of improvement with tricyclic therapy in depression. Arch Gen Psychiatry 25:247–255

    Google Scholar 

  • Fawcett J, Maas JW, Dekirmenjian H (1972) Depression and MHPG excretion: Response to dextroamphetamine and tricyclic antidepressants. Arch Gen Psychiatry 26:246–251

    PubMed  CAS  Google Scholar 

  • Frank E, Jarrett DB, Kuper DJ, Grochocinski VJ (1984) Biological and clinical predictors of response in recurrent depression. A preliminary report. Psychiatr Res 13:315–324

    Article  CAS  Google Scholar 

  • Friedel RO (1983) Clinical predictors of response: an update. In: Davis JM, Maas JE (eds) The affective disorders. American Psychiatric Association Press, New York, pp 379–384

    Google Scholar 

  • Gärtner HJ, Golfinopoulos G, Breyer-Pfaff U (1982) Response to maprotiline treatment in depressive patients, relationship to urinary MHPG excretion and plasma drug level. Pharmacopsychiatry 15:170–174

    Article  Google Scholar 

  • Garvey MJ, Schaffer CB, Tuason VB (1984) Comparison of pharmacological treatment response between situational and non-situational depressions. Br J Psychiatry 145:363–365

    Article  PubMed  CAS  Google Scholar 

  • Gitlin MJ, Gerner RH (1986) The dexamethasone suppression test and response to somatic treatment: a review. J Clin Psychiat 47:16–21

    CAS  Google Scholar 

  • Glassman AH, Roose SP (1981) Delusional depression: a distinct clinical entity? Arch Gen Psychiatry 38:424–427

    PubMed  CAS  Google Scholar 

  • Goodwin FK, Potter WZ (1978) The biology of affective illness: amine neurotransmitters and drug response. In: Cole JO, Schatzberg AF, Frazier SM (eds) Depression: biology, psycho-dynamics and treatment. Plenum Press, New York

    Google Scholar 

  • Goodwin FK, Post RM, Murphy DL (1973) Cerebrospinal fluid amine metabolites and therapies for depression. Program of the Scientific Proceedings of the American Psychiatric Association, pp 24–25

    Google Scholar 

  • Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z (1983) Dexamethasone suppression test in antidepressant treatment of melancholia: the process of normalization and test-retest reproductibility. Arch Gen Psychiatry 40:493–500

    PubMed  CAS  Google Scholar 

  • Guze SB, Woodruff RA, Clayton RJ (1975) The significance of psychotic affective disorders. Arch Gen Psychiatry 31:1147–1150

    Google Scholar 

  • Hagnell O, Lanke J, Rorsman B, Ojesjo L (1982) Are we entering an age of melancholy? Depressive illnesses in a prospective epidemiological study over 25 years: the Lundby Study, Sweden. Psychol Med 12:279–289

    Article  PubMed  CAS  Google Scholar 

  • Haug HJ, Fähndrich E (1986) Problems in defining response in therapy studies. Pharmacopsychiatry 19:170–171

    Article  Google Scholar 

  • Hirschfeld RMA, Klerman GL, Andreasen NC, Clayton PJ, Keller MB (1986) Psycho-social predictors of chronicity in depressed patients. Br J Psychiatry 148:648–654

    Article  PubMed  CAS  Google Scholar 

  • Höchli D, Riemann D, Zulley J, Berger M (1986 a) Initial REM-sleep suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder. Biol Psychiatry 21:1217–1220

    Article  PubMed  Google Scholar 

  • Höchli D, Riemann D, Zulley J, Berger M (1986 b) Is there a relationship between response to total sleep deprivation and efficacy of clomipramine treatment in depressed patients?Acta Psychiatr Scand 74:190–192

    Article  PubMed  Google Scholar 

  • Hohagen F (1992) Neurobiologische Grundlagen der Zwangsstörung. In: Hand I, Goodman WK, Evers U (Hrsg) Zwangsstörungen. Springer, Berlin Heidelberg New York Tokyo, pp 57–71

    Google Scholar 

  • Hollister LE (1981) Excretion of MHPG in depressed and geriatric patients and normal persons. Int Pharmacopsychiatry 16:138–143

    PubMed  CAS  Google Scholar 

  • Hollister LE, Davis KL, Berger PA (1980) Subtypes of depression based on excretion of MHPG and response to nortriptyline. Arch Gen Psychiatry 37:1107–1110

    PubMed  CAS  Google Scholar 

  • Holsboer F, Liebl R, Hofschuster E (1982) Repeated dexamethasone suppression test during depressive illness: normalization of test result compared with clinical improvement. J Affective Disord 4:93–101

    Article  CAS  Google Scholar 

  • Jarvik LF, Read SL, Mintz J, Neshkes RE (1983) Pretreatment orthostatic hypotension in geriatric depression: predictor of response to imipramine and doxepin. J Clin Psycho-pharmacol 3:368–372

    CAS  Google Scholar 

  • Joyce PR, Paykel ES (1989) Predictors of drug response in depression. Arch Gen Psychiatry 46:89–99

    PubMed  CAS  Google Scholar 

  • Kammen DP v, Murphy DL (1978) Prediction of imipramine antidepressant response by a one-d-amphetamine trial. Am J Psychiatry 135:1179–1184

    PubMed  Google Scholar 

  • Kaskey GB, Nasr S, Meltzer HY (1980) Drug treatment in delusional depression. Psychiatr Res 1:267–277

    Article  Google Scholar 

  • Kasper S, Yieira A (1989) Stimulation with dl-fenfluramine and antidepressive medication in major depressed inpatients. Pharmacopsychiatry 22:201

    Google Scholar 

  • Katz MM, Koslow SH, Maas JW, Frazer A, Bowden CL, Casper R, Croughan J, Kocsis J, Redmond E (1987) The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 17:297–309

    Article  PubMed  CAS  Google Scholar 

  • Keller MB, Klerman GL, Lavori PW, Coryell W, Endicott J, Taylor J (1984) Long-term outcome of episodes of major depression: clinical and public health significance. JAMA 252:788–792

    Article  PubMed  CAS  Google Scholar 

  • Keller MB, Lavori PW, Rice J, Coryell W, Hirschfeld RMA (1986) The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up. Am J Psychiatry 143:24–28

    PubMed  CAS  Google Scholar 

  • Kelwala S, Jons D, Sitaram N (1983) Monoamine metabolites as predictors of antidepressant response: a critique. Prog Neuropsychopharmacol Biol Psychiatry 7:229–240

    Article  PubMed  CAS  Google Scholar 

  • Khan A, Cohen S, Dager ST, Avery DH, Dunner DL (1989) Onset of response in relation to outcome in depressed outpatients with placebo and imipramine. J Affect Dis 17:33–38

    Article  PubMed  CAS  Google Scholar 

  • Kiloh LG, Ball JRB, Garside RF (1962) Prognostic factors in treatment of depressive states with imipramine. Br Med J 1:1225–1227

    Article  PubMed  CAS  Google Scholar 

  • Kiloh LG, Neilson M, Andrews G (1974) Response of depressed patients to methylamphet-amine. Br J Psychiatry 125:496–499

    Article  PubMed  CAS  Google Scholar 

  • Klein DF, Gittelman R, Quitkin R, Rifkin A (1981) Diagnosis and drug treatment of psychiatric disorders. Williams & Wilkins, Baltimore London

    Google Scholar 

  • Kocsis JH, Croughan JL, Katz MM, Butler TP, Secunda S, Bowden CL, Davis JM (1990) Response to treatment with antidepressants of patients with severe or moderate non-psychotic depression and of patients with psychotic depression. Am J Psychiatry 147:621–624

    PubMed  CAS  Google Scholar 

  • Koslow SH, Maas JW, Bowden CL, Davis JM, Hanin I, Javaid JI (1983) Cerebrospinal fluid and urinary biogenic amines and metabolites in depression, mama and healthy controls: a univariate analysis. Arch Gen Psychiatry 40:999–1010

    PubMed  CAS  Google Scholar 

  • Krog-Meyer I, Kirkegaard C, Kijne B et al. (1984) Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression. Am J Psychiatry 141:945–948

    PubMed  CAS  Google Scholar 

  • Kupfer DJ, Spiker DG (1981) Refractory depression: prediction of non-response by clinical indicators. J Clin Psychiatry 42:307:312

    Google Scholar 

  • Kupfer DJ, Foster FG, Reich L, Thompson KS, Weiss B (1976) EEG sleep changes as predictors in depression. Am J Psychiatry 133:622–626

    PubMed  CAS  Google Scholar 

  • Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH (1980) Depression, EEG sleep, and clinical response. Compr Psychiatry 21:212–220

    Article  PubMed  CAS  Google Scholar 

  • Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH (1981) Sleep and treatment prediction in endogenous depression. Am J Psychiatry 138:429–434

    Article  PubMed  CAS  Google Scholar 

  • Kupfer DJ, Targ E, Stack J (1982 a) Electroencephalographic sleep in unipolar depressive subjects. Support for a biological and familial classification. J Nerv Ment Dis 170:494–498

    Article  PubMed  CAS  Google Scholar 

  • Kupfer DJ, Shaw DH, Ulrich R, Coble PA, Spiker DG (1982 b) Application of automated REM-analysis in depression. Arch Gen Psychiatry 39:569–573

    PubMed  CAS  Google Scholar 

  • Levine J, Raskin A (1974) Predicting treatment responsiveness-resistiveness in a population of depressed patients. Pharmacopsychiatry 7:217–222

    Article  CAS  Google Scholar 

  • Liebowitz MR, Quitkin FM, Stewart JW et al. (1984) Phenelzine versus imipramine in atypical depression. Arch Gen Psychiatry 41:669–677

    PubMed  CAS  Google Scholar 

  • Loyd DW, Tsuang MT (1985) Duration criteria and long-term outcome in affective disorder and schizophrenia. J Affective Disord 9:35–39

    Article  CAS  Google Scholar 

  • Maas JW, Fawcett JA, Dekirmenjian H (1972) Catecholamine metabolism, depressive illness, and drug response. Arch Gen Psychiatry 26:252–262

    PubMed  CAS  Google Scholar 

  • Maas JW, Kocsis JH, Bowden CL, Davis JM, Redmond DE, Hanin I, Robins E (1982) Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment. Psychol Med 12:37–43

    Article  PubMed  CAS  Google Scholar 

  • Maas JW, Koslow SH, Davis J, Katz M, Frazer A, Bowden CL, Berman N, Gibbons R, Stokes P, Landis DH (1987) Catecholamine metabolism and disposition in healthy and depressed subjects. Arch Gen Psychiatry 44:337–344

    PubMed  CAS  Google Scholar 

  • McGrath PJ, Stewart JW, Harrison W et al. (1986) Phenelzine treatment of melancholia. J Clin Psychiatry 47:420–422

    PubMed  CAS  Google Scholar 

  • Modai J, Apter A, Golomb M, Wijsenbeck J (1979) Response to amitriptyline and urinary MHPG in bipolar depressive patients. Neuropsychobiology 5:181–184

    Article  PubMed  CAS  Google Scholar 

  • Möller HJ (1991) Therapieresistenz auf Antidepressiva. Risikofaktoren und Behandlungsmöglichkeiten. Nervenarzt 62:658–669

    PubMed  Google Scholar 

  • Möller HJ, van Praag HM (1992) Aggression und Autoaggression. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Möller HJ, Fischer G, Zerssen D v (1987) Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive patients. Eur Arch Psychiatr Neurol Sci 236:349–357

    Article  Google Scholar 

  • Morris JB, Beck AT (1974) The efficacy of antidepressant drugs. A review of research. Arch Gen Psychiatry 30:667–674

    PubMed  CAS  Google Scholar 

  • Nelson JC, Bowers MB (1978) Delusional unipolar depression: description and drug response. Arch Gen Psychiatry 35:1321–1328

    PubMed  CAS  Google Scholar 

  • Nies A, Robinson DS (1982) Monoamine oxidase inhibitors. In: Paykel ES (ed) Handbook of affective disorders. Churchill Livingston, Edinburgh

    Google Scholar 

  • Pare CMB (1985) The present status of monoamine oxidase inhibitors. Br J Psychiatry 146:576–584

    Article  PubMed  CAS  Google Scholar 

  • Paykel ES (1977) Response to treatment and depressive classification. In: Burrows GF (ed) Handbook of studies on depression. Excerpta Medica, Amsterdam, pp 21–47

    Google Scholar 

  • Paykel ES (1979) Predictors of treatment response. In: Paykel ES, Coppen A (eds) Psycho-pharmacology of affective disorders. Oxford University Press, pp 193–220

    Google Scholar 

  • Paykel ES, Prusoff BA, Klerman GI, Haskell D, DiMascio A (1973) Clinical response to amitriptyline among depressed women. J Nerv Ment Dis 156:149–165

    Article  PubMed  CAS  Google Scholar 

  • Paykel ES, Parker R, Penrose RJ, Rassaby E (1979) Depressive classification and prediction of response to phenelzine. Br J Psychiatry 134:572–581

    Article  PubMed  CAS  Google Scholar 

  • Paykel ES, Rowan P, Parker R, Bhat AV (1982) Response to phenelzine and amitriptyline in subtypes of outpatient depression. Arch Gen Psychiatry 39:1041–1049

    PubMed  CAS  Google Scholar 

  • Paykel ES, Hollyman JA, Freeling P, Sedgwick P (1988) Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affect Disord 14:83–95

    Article  PubMed  CAS  Google Scholar 

  • Peselow ED, Fieve RR (1982) Dexamethasone suppression test and response to antidepressants in depressed outpatients. N Engl J Med 307:1216–1217

    Article  PubMed  CAS  Google Scholar 

  • Pfohl B, Stangl D, Zimmerman M (1984) The implications of DSM-III personality disorders for patients with major depression. J Affective Disord 7:309–318

    Article  CAS  Google Scholar 

  • Philipp M, Beck V, Glocke M, Metz K, Scherhag R, Schmidt R (1985) Vorhersagbarkeit des Therapieansprechens depressiver Patienten auf Doxepin. In: Philipp M (Hrsg) Grundlagen und Erfolgsvorhersage der ambulanten Therapie mit Antidepressiva. Springer, Berlin Heidelberg New York Tokyo, pp 29–45

    Chapter  Google Scholar 

  • Prange AJ, Loosen PT, Wilson IC, Lipton MA (1984) The therapeutic use of hormones of the thyroid axis in depression. In: Post RM, Ballenger JC (eds) Neurobiology of mood disorders. Williams & Williams, Baltimore, pp 311–322

    Google Scholar 

  • Quitkin FM, Rifkin A, Klein DF (1978) Imipramine response in deluded depressive patients. Am J Psychiatry 135:806–811

    PubMed  CAS  Google Scholar 

  • Quitkin FM, Rabkin JD, Markowitz JM, Stewart JW, McGrath PJ, Harrison W (1987) Use of pattern analysis to identify true drug response: a replication. Arch Gen Psychiatry 44:256–264

    Google Scholar 

  • Ravaris CL, Robinson DS, Ives JO et al. (1980) Phenelzine and amitriptyline in the treatment of depression. Arch Gen Psychiatry 37:1075–1080

    PubMed  CAS  Google Scholar 

  • Rosenbaum AH, Schatzberger AF, Maruta T, Orsulak PJ, Cole JO, Grab EL, Schildkraut JJ (1980) MHPG as predictor of antidepressant response to imipramine and maprotiline. Am J Psychiatry 137:1090–1092

    PubMed  CAS  Google Scholar 

  • Rush AJ, Roffwarg HP, Giles DE, Schlesser MA, Fairchild C, Tarell J (1983) Psychobiological predictors of antidepressant drug response. Pharmacopsychiatrica 16:192–194

    Article  CAS  Google Scholar 

  • Rush AJ, Erman MK, Schlesser MA, Roffwarg HP, Vasavada N, Khatami M, Fairchild C, Giles DE (1985) Alprazolam vs amitriptyline in depression with reduced REM latencies. Arch Gen Psychiatry 42:1154–1159

    PubMed  CAS  Google Scholar 

  • Sauer H, Kick H, Minne HW, Schneider B (1986) Prediction of the amitriptyline response: psychopathology vs neuroendocrinology. Int Clin Psychopharmacol 1:284–295

    Article  PubMed  CAS  Google Scholar 

  • Schatzberg AF, Rosenbaum AH, Orsulak PJ, Rohde WA, Maruta T, Krug ER, Cole JO, Schildkraut JJ (1981) Towards a biological classification of depressive disorders III: pre-treatment urinary MHPG levels as predictors of response to treatment with maprotiline. Psychopharmacology 75:34–38

    Article  PubMed  CAS  Google Scholar 

  • Schmauss M (1993) Antidepressiva Behandlung depressiver Erkrankungen. In: Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen. Enke, Stuttgart, pp 277–287

    Google Scholar 

  • Schmauss M, Erfurth A (1989) Indikationen für eine Therapie mit MAO-Hemmern. Psychiatr Prax 16 [Suppl];2–6

    PubMed  Google Scholar 

  • Schmauss M, Meiler I (1989) Die „therapieresistenten” Depressionen — Ursachen und Behandlungsmöglichkeiten. Psychiatr Prax 16:101–108

    PubMed  CAS  Google Scholar 

  • Schneider LS, Sloane RB, Staples FR, Bender M (1986) Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression. J Clin Psychopharmacol 6:172–176

    Article  PubMed  CAS  Google Scholar 

  • Shawcross CR, Tyrer P (1985) Influence of personality on response to monoamine oxidase inhibitors and tricyclic antidepressants. J Psychiatr Res 19:557–562

    Article  PubMed  CAS  Google Scholar 

  • Spiegel R (1984) Zur Voraussage des Therapieerfolges mit Antidepressiva: Sind kurze REM-Latenzen diagnostisch und prognostisch zuverlässige Merkmale? Fortschr Neurol Psychiatr 52:302–311

    Article  PubMed  CAS  Google Scholar 

  • Spiker DG, Weiss JG, Dealy RS, Griffin SJ, Hanin I, Neil JP, Perry JM, Rossi AJ, Soloff PH (1985) The pharmacological treatment of delusional depression. Am J Psychiatry 142:430–436

    PubMed  CAS  Google Scholar 

  • Svendsen K, Christensen PG (1981) Duration of REM-sleep latency as predictor of effect of antidepressant therapy — a preliminary report. Acta Psychiatr Scand 64:238–243

    Article  PubMed  CAS  Google Scholar 

  • Targum SD (1984) Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse. Biol Psychiatry 19:305–318

    Article  PubMed  CAS  Google Scholar 

  • Tollefson GD (1983) Monoamine oxidase inhibitors: a review. J Clin Psychiatry 44:280–288

    PubMed  CAS  Google Scholar 

  • van Praag HM (1977) New evidence for serotonin-deficient depression. Neuropsychobiology 3:56–63

    Article  PubMed  Google Scholar 

  • van Praag HM, de Haan S (1980) Depression, vulnerability and 5-hydroxytryptophan prophylaxis. Psychiatr Res 3:75–83

    Article  Google Scholar 

  • Weissman MM, Leaf PJ, Holzer CE, Myers JK, Tischler GL (1984) The epidemiology of depression: an update on sex differences in rates. J Affective Disord 7:179–188

    Article  CAS  Google Scholar 

  • West ED, Dally PJ (1959) Effects of iproniazid on depressed syndromes. Br Med J 1:1491–1497

    Article  PubMed  CAS  Google Scholar 

  • White K, White J (1986) Tranylcypromine: patterns and predictors of response. J Clin Psychiatry 47:380–382

    PubMed  CAS  Google Scholar 

  • Wirz-Justice A, Pühringer W, Hole G (1976) Sleep deprivation and clomipramine in endogenous depression. Lancet 23:912

    Article  Google Scholar 

  • Wirz-Justice A, Pühringer W, Hole G (1979) Response to sleep deprivation as a predictor oftherapeutic results with antidepressant drugs. Am J Psychiatry 136:1222–1223

    PubMed  CAS  Google Scholar 

  • Wittenborn JR, Kiremitci N, Weber ESP (1973) The choice of alternative antidepressants. J Nerv Ment Dis 156:97–108

    Article  PubMed  CAS  Google Scholar 

  • Woggon B (1980) Veränderungen der psychopathologischen Symptomatik während 20tägiger antidepressiver oder neuroleptischer Behandlung. Psychiatr Clin 13:150–164

    CAS  Google Scholar 

  • Woggon B (1983) Prognose der Pharmakotherapie. Enke, Stuttgart

    Google Scholar 

  • Woggon B (1990) Frühansprechen auf Antidepressiva: Die prognostische Bedeutung der Probetherapie. In: Möller HJ (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York Tokyo, pp 33–39

    Google Scholar 

  • Woggon B (1992) Prädiktoren für das Ansprechen auf Psychopharmaka. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka Band 1 Allgemeine Grundlagen der Phar-makopsychiatrie. Springer, Wien, pp 475–484

    Google Scholar 

Download references

Authors
  1. M. Schmauss
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Heinrich-Hoffmann-Str. 10, 60528, Frankfurt am Main, Germany

    Burkhard Pflug

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schmauss, M. (1994). Prädiktoren für den antidepressiven Therapieerfolg. In: Pflug, B. (eds) Differenzierte Therapie mit trizyklischen Antidepressiva. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77887-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77887-2_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56129-3

  • Online ISBN: 978-3-642-77887-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation